Universe Pharmaceuticals Inc. (UPC) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -7.61M | 2.56M | -7.08M | -2.43M | -3.64M | 4.8M | -7.9M | 6.12M | -2.87M | 1.06M | 3.06M | 3.06M |
| Operating CF Margin % | -87.45% | 27.98% | -69.79% | -18.86% | -26.3% | 25.99% | -49.56% | 25.28% | -12.13% | 4.36% | 19.92% | 19.92% |
| Operating CF Growth % | -7.58% | 205.42% | -94.42% | -150.63% | 53.93% | -21.57% | -174.87% | 478.21% | -194.01% | -65.39% | -53.69% | - |
| Net Income | -387.3K | -3.28M | 4.37M | -13.1M | -5.45M | -715.43K | -8.74M | 1.73M | 4.17M | 7.15M | 3.78M | 3.78M |
| Depreciation & Amortization | 247.79K | 269.64K | 236.87K | 248.86K | 251K | 257.78K | 226.39K | 292.11K | 203.41K | 243.47K | 205.04K | 205.04K |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.26M | -1.6M | -3.87M | 0 | 0 |
| Deferred Taxes | 0 | 0 | -58.44K | 665.15K | 122.72K | 556.87K | -597.86K | -100.41K | -739.56K | 71.22K | -4.94K | -4.94K |
| Other Non-Cash Items | 370.6K | 0 | -10.23M | 10.41M | -236.38K | -252K | -192.46K | 5.64M | 1.65M | 3.59M | 11.36K | 11.36K |
| Working Capital Changes | -7.84M | 5.58M | -1.4M | -653.92K | 1.67M | 4.95M | 1.4M | 4.81M | -6.56M | -6.12M | -932.99K | -932.99K |
| Change in Receivables | -2.74M | 5.87M | 1.64M | -3.35M | 6.48M | -1.76M | 1.51M | -3.06M | 2.45M | -6.32M | -2.05M | -2.05M |
| Change in Inventory | 970.24K | -2.95M | 1.8M | -160.23K | -677.63K | -676.21K | 3.56M | -860.52K | -303.81K | -2.86M | 444.3K | 444.3K |
| Change in Payables | -5.79M | 2.66M | -2.99M | 3.14M | -6.29M | 7.93M | -145.61K | -1.75M | -3.34M | 5.8M | 319.71K | 319.71K |
| Cash from Investing | -209.07K | -132.74K | -293.63K | -67.66K | -43.52K | -646 | -3.85M | -55.09K | -27.01M | -50.88K | -25.9K | -25.9K |
| Capital Expenditures | -214.45K | -132.74K | -178.14K | -67.66K | -43.52K | -646 | -38.07K | -55.63K | -13.48M | -50.88K | -25.9K | -25.9K |
| CapEx % of Revenue | 2.46% | 1.45% | 1.76% | 0.53% | 0.31% | 0% | 0.24% | 0.23% | 56.91% | 0.21% | 0.17% | 0.17% |
| Acquisitions | 5.38K | 0 | 0 | 0 | 0 | 0 | -15 | 538 | 26.62M | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | -115.49K | 0 | 0 | 0 | -3.81M | 0 | -26.62M | 0 | 0 | 0 |
| Cash from Financing | -6.67M | 16.4M | 27.89M | 6.07M | -3.47M | 2.08M | 3.34M | -19.99K | 2.45M | 24.14M | 235.07K | 235.07K |
| Debt Issued (Net) | -6.67M | 1.4M | 8.95M | 0 | 0 | 0 | 3.34M | 0 | -1.57M | 2.19M | 0 | 0 |
| Equity Issued (Net) | 0 | 15M | 25M | 0 | 0 | 0 | 0 | 0 | 6.81M | 21.94M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | -6.07M | 6.07M | -3.47M | 2.08M | 0 | -19.99K | -2.79M | 0 | 235.07K | 235.07K |
| Net Change in Cash | -13.68M | 17.78M | 20.64M | 3.58M | -7.67M | 7.24M | -8.52M | 6.16M | -27.92M | 25.14M | 1.72M | 1.72M |
| Free Cash Flow | -7.78M | 2.46M | -7.37M | -2.5M | -3.68M | 4.8M | -7.94M | 6.06M | -16.35M | 1.01M | 3.03M | 3.03M |
| FCF Margin % | -89.41% | 26.92% | -72.71% | -19.38% | -26.61% | 25.98% | -49.8% | 25.05% | -69.04% | 4.15% | 19.75% | 19.75% |
| FCF Growth % | -5.57% | 198.68% | -100.14% | -152.05% | 53.6% | -20.86% | 51.46% | 501.89% | -639.46% | -66.78% | -53.78% | - |
| FCF per Share | -13.82 | 708.54 | -1213.18 | -410.94 | -621.92 | 810.07 | -1340.38 | 1023.56 | -3102.20 | 191.06 | 519.75 | 519.75 |
| FCF Conversion (FCF/Net Income) | 19.66x | -0.78x | -1.62x | 0.19x | 0.67x | -6.71x | 0.75x | 3.53x | -0.69x | 0.15x | 0.81x | 0.81x |
| Interest Paid | 0 | 0 | 304.52K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |